| Literature DB >> 24936298 |
Trine D Damgaard1, Jeanette A H Otte1, Lene Meinert2, Kirsten Jensen2, René Lametsch1.
Abstract
The antioxidative capacity of seven different porcine tissue hydrolysates (colon, appendix, rectum, pancreas, heart, liver, and lung) were tested by four different assays, including iron chelation, 2,2'-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radical scavenging, 2,2-Diphenyl-1-(2,4,6-trinitrophenyl) hydrazyl (DPPH) radical scavenging, and inhibition of lipid oxidation. All hydrolyzed tissues displayed antioxidant capacity in all four assays, with colon, liver, and appendix as the three most potent inhibitors of lipid oxidation (47, 29, and 27 mmol/L trolox equivalent antioxidant capacity [TEAC], respectively) and liver, colon, pancreas, and appendix as the four most potent iron chelators (92% ± 1.1, 79.3% ± 3.2, 77.1% ± 1.8, and 77% ± 2.3, respectively). Furthermore, colon and appendix showed good radical scavenging capacities with ABTS scavenging of 86.4% ± 2.1 and 84.4% ± 2.9 and DPPH scavenging of 17.6% ± 0.3 and 17.1% ± 0.2, respectively. Our results provide new knowledge about the antioxidant capacity of a variety of animal by-products, which can be transformed into antioxidant hydrolysates, thereby creating added value.Entities:
Keywords: Antioxidant capacity; enzymatic hydrolysis; meat by-products; pig
Year: 2014 PMID: 24936298 PMCID: PMC4048614 DOI: 10.1002/fsn3.106
Source DB: PubMed Journal: Food Sci Nutr ISSN: 2048-7177 Impact factor: 2.863
Dry matter content% (w/w) of the hydrolysates
| Liver | 13.8 |
| Pancreas | 13.4 |
| Lung | 9.3 |
| Heart | 8.7 |
| Rectum | 7.9 |
| Appendix | 6.7 |
| Colon | 5.9 |
Antioxidant capacity of the hydrolysates measured by iron chelation, ABTS and DPPH radical scavenging and inhibition of lipid oxidation
| Antioxidative capacity% | ||||
|---|---|---|---|---|
| Sample | TEAC (mmol/L) | Iron chelation | ABTS | DDPH |
| Colon | 47a (CI 37–61) | 79.3 ± 3.2b | 86.4 ± 2.1a | 17.6 ± 0.3b |
| Appendix | 27b (CI 22–36) | 77.0 ± 2.3b | 84.4 ± 2.9ab | 17.1 ± 0.2b |
| Rectum | 13c (CI 9–18) | 66.5 ± 3.3c | 82.1 ± 3.8ab | 12.1 ± 0.3d |
| Pancreas | 19bc (CI 10–30) | 77.1 ± 1.8b | 84.3 ± 3.4ab | 13.4 ± 0.2c |
| Liver | 29ab (CI 22–38) | 92.0 ± 1.1a | 79.2 ± 4.2ab | 9.9 ± 0.3e |
| Lung | 22b (CI 18–24) | 38.0 ± 2.4d | 87.9 ± 4.1a | 9.7 ± 0.2e |
| Heart | 14c (CI 13–16) | 20.8 ± 9.3e | 76.5 ± 7.2b | 25.4 ± 0.3a |
| Trolox | 59.9 ± 7.8 | 13.9 ± 2.9 | ||
Values with different lowercase letters in the same column are significantly different at P < 0.05. ABTS, 2,2′-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid); DPPH, 2,2-Diphenyl-1-(2,4,6-trinitrophenyl) hydrazyl; TEAC, trolox equivalent antioxidant capacity.
Values for inhibition of lipid oxidation are means with 95% confidence intervals (CI).
Values for iron chelation, ABTS, and DPPH radical scavenging are means ± standard deviations.
Inhibition of lipid oxidation was tested at 20 μL hydrolysate converted to 100% DM.
Iron chelation and DPPH radical scavenging was tested at 5 mg/mL and trolox at 0.25 mmol/L.
ABTS radical scavenging was tested at 50 μg/mL and trolox at 32 μmol/L.
Schematic representation of the antioxidant capacity of the hydrolysates ranked from highest to lowest capacity
| Lipid oxidation inhibition | Iron chelation | ABTS | DPPH | |
|---|---|---|---|---|
| Highest antioxidative capacity | Colonab | Livera | Lunga | Hearta |
| Livera | Colonb | Colona | Colonb | |
| Appendixa | Pancreasb | Appendixab | Appendixb | |
| Lungac | Appendixb | Pancreasab | Pancreasc | |
| Pancreasac | Rectumc | Rectumab | Rectumd | |
| Heartc | Lungd | Liverab | Livere | |
| Lowest antioxidant activity | Rectumc | Hearte | Heartb | Lunge |
Hydrolysates with different letters in the same columns are significantly different at P < 0.05. ABTS, 2,2′-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid); DPPH, 2,2-Diphenyl-1-(2,4,6-trinitrophenyl) hydrazyl.